Oral anticoagulant-associated intracerebral hemorrhage

Journal of Neurology

Volumn 259, Issue 2, 2012, Pages 212-224

  Cervera, Álvaro ^a   Amaro, Sergio ^a   Chamorro, Ángel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Intracerebral hemorrhage; Oral anticoagulation; Outcome; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; CYTOKINE; DABIGATRAN; FRESH FROZEN PLASMA; GLUTAMIC ACID; HEME; HEPARIN; IRON; MATRIX METALLOPROTEINASE; PHYTOMENADIONE; PROTHROMBINEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

AGING; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN REGION; BRAIN STEM; BRAIN TISSUE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; GENETIC ANALYSIS; HEREDITY; HUMAN; INCIDENCE; LEUKOARAIOSIS; MICROHEMORRHAGE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE; VASCULAR AMYLOIDOSIS;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; HUMANS; INCIDENCE; WARFARIN;

EID: 84856731643     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6153-3     Document Type: Review

References (124)

1. DS Whitlon JA Sadowski JW Suttie 1978 Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition Biochemistry 17 8 1371 1377 646989 1:CAS:528:DyaE1cXktVWkur0%3D 10.1021/bi00601a003
2. GW Albers P Amarenco JD Easton RL Sacco P Teal 2008 Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 6 Suppl 630S 669S 18574275 1:CAS:528:DC%2BD1cXptVKhs70%3D 10.1378/chest.08-0720
3. S Schulman RJ Beyth C Kearon MN Levine 2008 Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) Chest 133 6 Suppl 257S 298S 18574268 1:CAS:528:DC%2BD1cXptVKhsr4%3D 10.1378/chest.08-0674
4. LJ Schurgers H Aebert C Vermeer B Bultmann J Janzen 2004 Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 104 10 3231 3232 15265793 1:CAS:528:DC%2BD2cXhtVWhurrM 10.1182/blood-2004-04-1277
5. RG Hart SB Tonarelli LA Pearce 2005 Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas Stroke 36 7 1588 1593 15947271 10.1161/01.STR.0000170642.39876.f2
6. RG Hart BS Boop DC Anderson 1995 Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 8 1471 1477 7631356 1:STN:280:DyaK2MzlslyntA%3D%3D 10.1161/01.STR.26.8.1471
7. ML Flaherty B Kissela D Woo D Kleindorfer K Alwell P Sekar CJ Moomaw M Haverbusch JP Broderick 2007 The increasing incidence of anticoagulant- associated intracerebral hemorrhage Neurology 68 2 116 121 17210891 1:STN:280:DC%2BD2s%2FhsFSiuw%3D%3D 10.1212/01.wnl.0000250340.05202.8b
8. MN Levine G Raskob RJ Beyth C Kearon S Schulman 2004 Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy Chest 126 3 Suppl 287S 310S 15383476 1:CAS:528:DC%2BD2cXptV2msLY%3D 10.1378/chest.126.3-suppl.287S
9. -(1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (13):1449-1457
10. T Steiner J Rosand M Diringer 2006 Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions Stroke 37 1 256 262 16339459 1:CAS:528:DC%2BD2MXhtlagsb%2FP 10.1161/01.STR. 0000196989.09900.f8
11. NL Smith BM Psaty CD Furberg R White JA Lima AB Newman TA Manolio 1999 Temporal trends in the use of anticoagulants among older adults with atrial fibrillation Arch Intern Med 159 14 1574 1578 10421280 1:STN:280: DyaK1MzkslKnug%3D%3D 10.1001/archinte.159.14.1574
12. G Xi RF Keep JT Hoff 2006 Mechanisms of brain injury after intracerebral haemorrhage Lancet Neurol 5 1 53 63 16361023 10.1016/S1474-4422(05)70283-0
13. GA Rosenberg M Navratil 1997 Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat Neurology 48 4 921 926 9109878 1:CAS:528:DyaK2sXjtVWmur4%3D
14. J Castillo A Davalos J Alvarez-Sabin JM Pumar R Leira Y Silva J Montaner CS Kase 2002 Molecular signatures of brain injury after intracerebral hemorrhage Neurology 58 4 624 629 11865143 1:CAS:528:DC%2BD38Xit1Wnu78%3D
15. J Wang S Dore 2007 Inflammation after intracerebral hemorrhage J Cereb Blood Flow Metab 27 5 894 908 17033693 1:CAS:528:DC%2BD2sXlvVSktr0%3D
16. RT Figueiredo PL Fernandez DS Mourao-Sa BN Porto FF Dutra LS Alves MF Oliveira PL Oliveira AV Graca-Souza MT Bozza 2007 Characterization of heme as activator of Toll-like receptor 4 J Biol Chem 282 28 20221 20229 17502383 1:CAS:528:DC%2BD2sXnsFWntL4%3D 10.1074/jbc.M610737200
17. I Kruman AJ Bruce-Keller D Bredesen G Waeg MP Mattson 1997 Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis J Neurosci 17 13 5089 5100 9185546 1:CAS:528:DyaK2sXktVOitL0%3D
18. AR Zazulia MN Diringer TO Videen RE Adams K Yundt V Aiyagari RL Grubb Jr WJ Powers 2001 Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage J Cereb Blood Flow Metab 21 7 804 810 11435792 1:STN:280: DC%2BD3MznvFWisQ%3D%3D 10.1097/00004647-200107000-00005
19. SA Mayer A Lignelli ME Fink DB Kessler CE Thomas R Swarup RL Van Heertum 1998 Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study Stroke 29 9 1791 1798 9731596 1:STN:280: DyaK1cvgtVehsA%3D%3D 10.1161/01.STR.29.9.1791
20. AH Ropper NT Zervas 1982 Cerebral blood flow after experimental basal ganglia hemorrhage Ann Neurol 11 3 266 271 7092179 1:STN:280: DyaL383ivFOntQ%3D%3D 10.1002/ana.410110306
21. Suzuki J, Ebina T (1980) Sequential changes in tissue surrounding ICH. In: Pia HWLC, Zierski J (eds) Spontaneous intracerebral hematomas. Springer, Berlin, pp 121-128
22. SA Mayer NC Brun K Begtrup J Broderick S Davis MN Diringer BE Skolnick T Steiner 2008 Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 358 20 2127 2137 18480205 1:CAS:528:DC%2BD1cXlvFCrs70%3D 10.1056/NEJMoa0707534
23. Y Katayama DP Becker T Tamura K Ikezaki 1990 Early cellular swelling in experimental traumatic brain injury: a phenomenon mediated by excitatory amino acids Acta Neurochir 51 271 273 1:STN:280:DyaK3M3htlOnuw%3D%3D
24. GY Yang AL Betz TL Chenevert JA Brunberg JT Hoff 1994 Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats J Neurosurg 81 1 93 102 8207532 1:STN:280:DyaK2c3mslGrtw%3D%3D 10.3171/jns.1994.81.1.0093
25. KR Wagner G Xi Y Hua M Kleinholz GM de Courten-Myers RE Myers JP Broderick TG Brott 1996 Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter Stroke 27 3 490 497 8610319 1:STN:280:DyaK287nsFyksA%3D%3D 10.1161/01.STR.27.3.490
26. T Brott J Broderick W Barsan R Kothari T Tomsick J Spilker G Huster 1992 Hyper-acute clot retraction in spontaneous intracerebral hemorrhage Stroke 23 141 10.1161/01.STR.23.5.632
27. JM Gebel TG Brott CA Sila TA Tomsick E Jauch S Salisbury J Khoury R Miller A Pancioli JE Duldner EJ Topol JP Broderick 2000 Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage Stroke 31 3 596 600 10700491 1:STN:280: DC%2BD3c7mslehtw%3D%3D 10.1161/01.STR.31.3.596
28. Y Hua RF Keep JT Hoff G Xi 2007 Brain injury after intracerebral hemorrhage: the role of thrombin and iron Stroke 38 2 Suppl 759 762 17261733 1:CAS:528:DC%2BD2sXhtVKltLo%3D 10.1161/01.STR.0000247868.97078.10
29. G Xi G Reiser RF Keep 2003 The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 84 1 3 9 12485396 1:CAS:528:DC%2BD3sXhtF2jtQ%3D%3D 10.1046/j.1471-4159.2003.01268.x
30. KR Lee GP Colon AL Betz RF Keep S Kim JT Hoff 1996 Edema from intracerebral hemorrhage: the role of thrombin J Neurosurg 84 1 91 96 8613842 1:CAS:528:DyaK28XlsVGmtw%3D%3D 10.3171/jns.1996.84.1.0091
31. KR Lee AL Betz RF Keep TL Chenevert S Kim JT Hoff 1995 Intracerebral infusion of thrombin as a cause of brain edema J Neurosurg 83 6 1045 1050 7490619 1:STN:280:DyaK28%2Fos1yksA%3D%3D 10.3171/jns.1995.83.6.1045
32. T Kitaoka Y Hua G Xi JT Hoff RF Keep 2002 Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage Stroke 33 12 3012 3018 12468805 1:CAS:528:DC%2BD38XptVShtrY%3D 10.1161/01.STR.0000037673.17260.1B
33. E Brodin I Seljeflot H Arnesen M Hurlen H Appelbom JB Hansen 2009 Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment Thromb Res 123 4 573 579 18474393 1:CAS:528: DC%2BD1MXhtlKqs7s%3D 10.1016/j.thromres.2008.03.018
34. AM Holbrook JA Pereira R Labiris H McDonald JD Douketis M Crowther PS Wells 2005 Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 10 1095 1106 15911722 1:CAS:528:DC%2BD2MXlsFaju78%3D 10.1001/archinte.165.10.1095
35. C Gasse J Hollowell CR Meier WE Haefeli 2005 Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin Thromb Haemost 94 3 537 543 16268469 1:CAS:528:DC%2BD2MXhtVaqur3L
36. AK Jonsson O Spigset I Jacobsson S Hagg 2007 Cerebral haemorrhage induced by warfarin: the influence of drug-drug interactions Pharmacoepidemiol Drug Saf 16 3 309 315 16858720 10.1002/pds.1291 1:CAS:528:DC%2BD2sXkt1agt7w%3D
37. J Hirsh V Fuster J Ansell JL Halperin 2003 American Heart Association/American College of Cardiology Foundation guide to warfarin therapy Circulation 107 12 1692 1711 12668507 10.1161/01.CIR.0000063575.17904.4E
38. M Battistella MM Mamdami DN Juurlink L Rabeneck A Laupacis 2005 Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors Arch Intern Med 165 2 189 192 15668365 1:CAS:528:DC%2BD2MXhsFalsrc%3D 10.1001/archinte.165.2.189
39. GH Lee SU Kwon DW Kang 2008 Warfarin-induced intracerebral hemorrhage associated with microbleeds J Clin Neurol (Seoul, Korea) 4 3 131 133 10.3988/jcn.2008.4.3.131
40. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group 1997 A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin Ann Neurol 42 6 857 865 10.1002/ana.410420606
41. EE Smith J Rosand KA Knudsen EM Hylek SM Greenberg 2002 Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke Neurology 59 2 193 197 12136056 1:STN:280:DC%2BD38zos12rsQ%3D%3D
42. A Tanaka Y Ueno Y Nakayama K Takano S Takebayashi 1999 Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas Stroke 30 8 1637 1642 10436114 1:STN:280:DyaK1MzmsFCmtA%3D%3D 10.1161/01.STR.30.8.1637
43. F Fazekas R Kleinert G Roob G Kleinert P Kapeller R Schmidt HP Hartung 1999 Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds AJNR 20 4 637 642 10319975 1:STN:280:DyaK1M3ltFKqsQ%3D%3D
44. YH Fan L Zhang WW Lam VC Mok KS Wong 2003 Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke Stroke 34 10 2459 2462 12958325 10.1161/01.STR.0000090841.90286. 81
45. H Naka E Nomura T Takahashi S Wakabayashi Y Mimori H Kajikawa T Kohriyama M Matsumoto 2006 Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types AJNR 27 4 830 835 16611773 1:STN:280:DC%2BD283gsVGmsQ%3D%3D
46. SH Lee WS Ryu JK Roh 2009 Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage Neurology 72 2 171 176 19139370 1:CAS:528:DC%2BD1MXhsVykug%3D%3D 10.1212/01.wnl.0000339060.11702.dd
47. RJ Beyth LM Quinn CS Landefeld 1998 Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 2 91 99 9727814 1:CAS:528:DyaK1cXlvVamsr4%3D 10.1016/S0002-9343(98) 00198-3
48. PM Kuijer BA Hutten MH Prins HR Buller 1999 Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Arch Intern Med 159 5 457 460 10074953 1:STN:280:DyaK1M7ntlanug%3D%3D 10.1001/archinte.159. 5.457
49. TI Shireman JD Mahnken PA Howard TF Kresowik Q Hou EF Ellerbeck 2006 Development of a contemporary bleeding risk model for elderly warfarin recipients Chest 130 5 1390 1396 17099015 10.1378/chest.130.5.1390
50. AJ Camm P Kirchhof GY Lip U Schotten I Savelieva S Ernst IC Van Gelder N Al-Attar G Hindricks B Prendergast H Heidbuchel O Alfieri A Angelini D Atar P Colonna R De Caterina J De Sutter A Goette B Gorenek M Heldal SH Hohloser P Kolh JY Le Heuzey P Ponikowski FH Rutten 2010 Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2369 2429 20802247 10.1093/eurheartj/ehq278
51. D Woo LR Sauerbeck BM Kissela JC Khoury JP Szaflarski J Gebel R Shukla AM Pancioli EC Jauch AG Menon R Deka JA Carrozzella CJ Moomaw RN Fontaine JP Broderick 2002 Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study Stroke 33 5 1190 1195 11988589 10.1161/01.STR.0000014774.88027.22
52. MH Eckman LK Wong YO Soo W Lam SR Yang SM Greenberg J Rosand 2008 Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help? Stroke 39 12 3308 3315 18845797 10.1161/STROKEAHA.108.523159
53. R Loebstein H Yonath D Peleg S Almog M Rotenberg A Lubetsky J Roitelman D Harats H Halkin D Ezra 2001 Interindividual variability in sensitivity to warfarin-Nature or nurture? Clin Pharmacol Ther 70 2 159 164 11503010 1:CAS:528:DC%2BD3MXmslygs74%3D 10.1067/mcp.2001.117444
54. GP Aithal CP Day PJ Kesteven AK Daly 1999 Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Lancet 353 9154 717 719 10073515 1:STN:280:DyaK1M7ntFGhsQ%3D%3D 10.1016/S0140-6736(98)04474-2
55. MJ Rieder AP Reiner BF Gage DA Nickerson CS Eby HL McLeod DK Blough KE Thummel DL Veenstra AE Rettie 2005 Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose N Engl J Med 352 22 2285 2293 15930419 1:CAS:528:DC%2BD2MXksl2ltrk%3D 10.1056/NEJMoa044503
56. TE Klein RB Altman N Eriksson BF Gage SE Kimmel MT Lee NA Limdi D Page DM Roden MJ Wagner MD Caldwell JA Johnson 2009 Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 360 8 753 764 19228618 10.1056/NEJMoa0809329
57. T Li CY Chang DY Jin PJ Lin A Khvorova DW Stafford 2004 Identification of the gene for vitamin K epoxide reductase Nature 427 6974 541 544 14765195 1:CAS:528:DC%2BD2cXpsFWhuw%3D%3D 10.1038/nature02254
58. M Wadelius LY Chen K Downes J Ghori S Hunt N Eriksson O Wallerman H Melhus C Wadelius D Bentley P Deloukas 2005 Common VKORC1 and GGCX polymorphisms associated with warfarin dose Pharmacogenomics J 5 4 262 270 15883587 1:CAS:528:DC%2BD2MXmsVyjs78%3D 10.1038/sj.tpj.6500313
59. UI Schwarz MD Ritchie Y Bradford C Li SM Dudek A Frye-Anderson RB Kim DM Roden CM Stein 2008 Genetic determinants of response to warfarin during initial anticoagulation N Engl J Med 358 10 999 1008 18322281 1:CAS:528: DC%2BD1cXjtVSrsLs%3D 10.1056/NEJMoa0708078
60. Genes for Cerebral Hemorrhage on Anticoagulation (GOCHA) Collaborative Group (2009) Exploiting common genetic variation to make anticoagulation safer. Stroke 40(3 Suppl):S64-S66
61. ML Flaherty M Haverbusch P Sekar B Kissela D Kleindorfer CJ Moomaw L Sauerbeck A Schneider JP Broderick D Woo 2006 Long-term mortality after intracerebral hemorrhage Neurology 66 8 1182 1186 16636234 1:STN:280: DC%2BD283ivFSnuw%3D%3D 10.1212/01.wnl.0000208400.08722.7c
62. MA Foulkes PA Wolf TR Price JP Mohr DB Hier 1988 The Stroke Data Bank: design, methods, and baseline characteristics Stroke 19 5 547 554 3363586 1:STN:280:DyaL1c3gsFChtQ%3D%3D 10.1161/01.STR.19.5.547
63. KK Andersen TS Olsen C Dehlendorff LP Kammersgaard 2009 Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors Stroke 40 6 2068 2072 19359645 10.1161/STROKEAHA.108.540112
64. R Leira A Davalos Y Silva A Gil-Peralta J Tejada M Garcia J Castillo 2004 Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors Neurology 63 3 461 467 15304576 1:STN:280: DC%2BD2cvgtFKrtg%3D%3D
65. B Cucchiara S Messe L Sansing S Kasner P Lyden 2008 Hematoma growth in oral anticoagulant related intracerebral hemorrhage Stroke 39 11 2993 2996 18703803 1:CAS:528:DC%2BD1cXht1KltrvJ 10.1161/STROKEAHA.108.520668
66. CL Franke J de Jonge JC van Swieten AA Op de Coul J van Gijn 1990 Intracerebral hematomas during anticoagulant treatment Stroke 21 5 726 730 2339452 1:STN:280:DyaK3c3lt1aktw%3D%3D 10.1161/01.STR.21.5.726
67. J Rosand MH Eckman KA Knudsen DE Singer SM Greenberg 2004 The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage Arch Intern Med 164 8 880 884 15111374 1:CAS:528:DC%2BD2cXkt1Ojtro%3D 10.1001/archinte.164.8.880
68. T Kawamata M Takeshita O Kubo M Izawa M Kagawa K Takakura 1995 Management of intracranial hemorrhage associated with anticoagulant therapy Surg Neurol 44 5 438 442 8629228 1:STN:280:DyaK283ivV2ksw%3D%3D 10.1016/0090-3019(95)00249-9 (discussion 443)
69. CS Kase RK Robinson RW Stein LD DeWitt DB Hier DL Harp JP Williams LR Caplan JP Mohr 1985 Anticoagulant-related intracerebral hemorrhage Neurology 35 7 943 948 4010961 1:STN:280:DyaL2M3ktV2nug%3D%3D
70. ML Flaherty M Haverbusch P Sekar BM Kissela D Kleindorfer CJ Moomaw JP Broderick D Woo 2006 Location and outcome of anticoagulant-associated intracerebral hemorrhage Neurocrit Care 5 3 197 201 17290088 10.1385/NCC:5:3:197
71. RG Hart 2000 What causes intracerebral hemorrhage during warfarin therapy? Neurology 55 7 907 908 11061242 1:STN:280:DC%2BD3crgvVOktQ%3D%3D
72. ML Flaherty H Tao M Haverbusch P Sekar D Kleindorfer B Kissela P Khatri B Stettler O Adeoye CJ Moomaw JP Broderick D Woo 2008 Warfarin use leads to larger intracerebral hematomas Neurology 71 14 1084 1089 18824672 1:CAS:528:DC%2BD1cXhtFCisbjI 10.1212/01.wnl.0000326895.58992.27
73. JJ Flibotte N Hagan J O'Donnell SM Greenberg J Rosand 2004 Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology 63 6 1059 1064 15452298 1:CAS:528:DC%2BD2cXntlOrsro%3D
74. AY Zubkov JN Mandrekar DO Claassen EM Manno EF Wijdicks AA Rabinstein 2008 Predictors of outcome in warfarin-related intracerebral hemorrhage Arch Neurol 65 10 1320 1325 18852345 10.1001/archneur.65.10.1320
75. L Sjoblom HG Hardemark A Lindgren B Norrving M Fahlen M Samuelsson L Stigendal D Stockelberg A Taghavi L Wallrup J Wallvik 2001 Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study Stroke 32 11 2567 2574 11692018 1:CAS:528: DC%2BD3MXptVGqsLw%3D 10.1161/hs1101.098523
76. HB Huttner PD Schellinger M Hartmann M Kohrmann E Juettler J Wikner S Mueller U Meyding-Lamade R Strobl U Mansmann S Schwab T Steiner 2006 Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates Stroke 37 6 1465 1470 16675739 1:CAS:528:DC%2BD28Xksl2is7k%3D 10.1161/01.STR.0000221786.81354.d6
77. A Oden M Fahlen 2002 Oral anticoagulation and risk of death: a medical record linkage study BMJ (Clinical research ed) 325 7372 1073 1075 10.1136/bmj.325.7372.1073
78. S Koo N Kucher PL Nguyen J Fanikos PW Marks SZ Goldhaber 2004 The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage Arch Intern Med 164 14 1557 1560 15277289 10.1001/archinte.164.14.1557
79. MI Aguilar RG Hart CS Kase WD Freeman BJ Hoeben RC Garcia JE Ansell SA Mayer B Norrving J Rosand T Steiner EF Wijdicks T Yamaguchi M Yasaka 2007 Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion Mayo Clin Proc 82 1 82 92 17285789 1:CAS:528: DC%2BD2sXhtVCmsL4%3D
80. K Fredriksson B Norrving LG Stromblad 1992 Emergency reversal of anticoagulation after intracerebral hemorrhage Stroke 23 7 972 977 1615547 1:STN:280:DyaK38zhtF2rsQ%3D%3D 10.1161/01.STR.23.7.972
81. TG Phan M Koh EF Wijdicks 2000 Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk Arch Neurol 57 12 1710 1713 11115236 1:STN:280:DC%2BD3M%2FntFGqsw%3D%3D 10.1001/archneur.57.12.1710
82. EF Wijdicks WI Schievink RD Brown CJ Mullany 1998 The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves Neurosurgery 42 4 769 773 9574641 1:STN:280:DyaK1c3jtlyhug%3D%3D 10.1097/00006123-199804000-00053
83. F Dentali W Ageno M Crowther 2006 Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms J Thromb Haemost 4 9 1853 1863 16961594 1:CAS:528:DC%2BD28XhtVOntrbP 10.1111/j.1538-7836. 2006.01986.x
84. JN Goldstein SH Thomas V Frontiero A Joseph C Engel R Snider EE Smith SM Greenberg J Rosand 2006 Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage Stroke 37 1 151 155 16306465 10.1161/01.STR.0000195047.21562.23
85. TE Warkentin MA Crowther 2002 Reversing anticoagulants both old and new Can J Anaesth 49 6 S11 S25 12557411
86. CA Leissinger PM Blatt WK Hoots B Ewenstein 2008 Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2 137 143 17729241 1:CAS:528:DC%2BD1cXitFKrs78%3D 10.1002/ajh.21046
87. FE Preston ST Laidlaw B Sampson S Kitchen 2002 Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients Br J Haematol 116 3 619 624 11849221 1:CAS:528:DC%2BD38XislSnsL8%3D 10.1046/j.0007-1048.2001.03295.x
88. L van Aart HW Eijkhout JS Kamphuis M Dam ME Schattenkerk TJ Schouten B Ploeger PF Strengers 2006 Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial Thromb Res 118 3 313 320 16182346 10.1016/j.thromres.2005.08.005 1:CAS:528: DC%2BD28Xntlyqt7c%3D
89. T Kuwashiro M Yasaka R Itabashi H Nakagaki F Miyashita H Naritomi K Minematsu 2011 Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage Cerebrovasc Dis 31 2 170 176 21135553 1:CAS:528: DC%2BC3MXmsVKhsw%3D%3D 10.1159/000321766
90. WD Freeman TG Brott KM Barrett PR Castillo HG Deen Jr LF Czervionke JF Meschia 2004 Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage Mayo Clin Proc 79 12 1495 1500 15595332 1:CAS:528:DC%2BD2MXitF2ntw%3D%3D 10.4065/79.12.1495
91. J Lin WC Hanigan M Tarantino J Wang 2003 The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings J Neurosurg 98 4 737 740 12691397 1:CAS:528:DC%2BD3sXjtFKqsbY%3D 10.3171/jns.2003.98.4.0737
92. DL Brody V Aiyagari AM Shackleford MN Diringer 2005 Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage Neurocrit Care 2 3 263 267 16159073 10.1385/NCC:2:3:263
93. SB Lee EM Manno KF Layton EF Wijdicks 2006 Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP Neurology 67 7 1272 1274 17030765 1:CAS:528:DC%2BD28XhtFyqtb7N 10.1212/01.wnl.0000238104.75563.2f
94. M Yasaka T Sakata K Minematsu H Naritomi 2002 Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Thromb Res 108 1 25 30 12586128 10.1016/S0049-3848(02) 00402-4
95. S Illanes W Zhou S Schwarting S Heiland R Veltkamp 2011 Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage Stroke 42 1 191 195 21127298 1:CAS:528: DC%2BC3MXhtlOitLw%3D 10.1161/STROKEAHA.110.593541
96. JP Hanley 2004 Warfarin reversal J Clin Pathol 57 11 1132 1139 15509671 1:CAS:528:DC%2BD2cXhtVKisb3O 10.1136/jcp.2003.008904
97. M Bertram M Bonsanto W Hacke S Schwab 2000 Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation J Neurol 247 3 209 214 10787117 1:STN:280:DC%2BD3c3ks1Oqug%3D%3D 10.1007/s004150050565
98. A Lieberman WK Hass R Pinto WO Isom M Kupersmith G Bear R Chase 1978 Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves Stroke 9 1 18 24 622739 1:STN:280:DyaE1c%2FpslCqsg%3D%3D 10.1161/01.STR.9.1.18
99. AC Butler RC Tait 1998 Management of oral anticoagulant-induced intracranial haemorrhage Blood Rev 12 1 35 44 9597196 1:STN:280: DyaK1c3lvFCrtg%3D%3D 10.1016/S0268-960X(98)90028-5
100. RR Leker O Abramsky 1998 Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma Neurology 50 5 1489 1491 9596017 1:STN:280:DyaK1c3lsFCmtA%3D%3D
101. T Nakagawa T Kubota Y Handa H Kawano K Sato 1995 Intracranial hemorrhage due to long-term anticoagulant therapy in patients with prosthetic heart valves-four case reports Neurol Med Chir 35 3 156 159 1:STN:280: DyaK2M3osl2htQ%3D%3D 10.2176/nmc.35.156
102. JH Tinker S Tarhan 1978 Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations JAMA 239 8 738 739 621894 1:STN:280:DyaE1c%2FovFyltQ%3D%3D 10.1001/jama.1978. 03280350062016
103. A Chamorro O Busse V Obach D Toni P Sandercock JC Reverter A Cervera F Torres A Davalos 2005 The rapid anticoagulation prevents ischemic damage study in acute stroke-final results from the writing committee Cerebrovasc Dis 19 6 402 404 10.1159/000086100 15925874 1:STN:280:DC%2BD2MzjvVOgtw%3D%3D 10.1159/000086100
104. MS Pessin CJ Estol F Lafranchise LR Caplan 1993 Safety of anticoagulation after hemorrhagic infarction Neurology 43 7 1298 1303 8327127 1:STN:280:DyaK3szhslWrsw%3D%3D
105. A Chamorro N Vila A Saiz M Alday E Tolosa 1995 Early anticoagulation after large cerebral embolic infarction: a safety study Neurology 45 5 861 865 7746397 1:STN:280:DyaK2M3msFWrtA%3D%3D
106. KM Einhaupl A Villringer W Meister S Mehraein C Garner M Pellkofer RL Haberl HW Pfister P Schmiedek 1991 Heparin treatment in sinus venous thrombosis Lancet 338 8767 597 600 1679154 1:STN:280:DyaK3MzltV2nuw%3D%3D 10.1016/0140-6736(91)90607-Q
107. J Stam SF De Bruijn G DeVeber 2002 Anticoagulation for cerebral sinus thrombosis Cochrane database of systematic reviews (Online) 4 CD002005
108. A Chamorro 2001 Immediate anticoagulation in acute focal brain ischemia revisited: gathering the evidence Stroke 32 2 577 578 11157200 1:STN:280:DC%2BD3M3msFCgsg%3D%3D 10.1161/01.STR.32.2.577
109. KA Knudsen J Rosand D Karluk SM Greenberg 2001 Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria Neurology 56 4 537 539 11222803 1:STN:280:DC%2BD3M7ps1Kgug%3D%3D
110. PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358(9287):1033-1041
111. HC O'Donnell J Rosand KA Knudsen KL Furie AZ Segal RI Chiu D Ikeda SM Greenberg 2000 Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage N Engl J Med 342 4 240 245 10648765 10.1056/NEJM200001273420403
112. MH Eckman J Rosand KA Knudsen DE Singer SM Greenberg 2003 Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis Stroke 34 7 1710 1716 12805495 10.1161/01.STR.0000078311.18928.16
113. J Stangier 2008 Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate Clin Pharmacokinet 47 5 285 295 18399711 1:CAS:528:DC%2BD1cXntVWgsbw%3D 10.2165/00003088-200847050-00001
114. SJ Connolly MD Ezekowitz S Yusuf J Eikelboom J Oldgren A Parekh J Pogue PA Reilly E Themeles J Varrone S Wang M Alings D Xavier J Zhu R Diaz BS Lewis H Darius HC Diener CD Joyner L Wallentin 2009 Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 1139 1151 19717844 1:CAS:528:DC%2BD1MXhtFOjsLnN 10.1056/NEJMoa0905561
115. BF Gage 2009 Can we rely on RE-LY? N Engl J Med 361 12 1200 1202 19717843 1:CAS:528:DC%2BD1MXhtFOjsLnE 10.1056/NEJMe0906886
116. J van Ryn J Stangier S Haertter KH Liesenfeld W Wienen M Feuring A Clemens 2010 Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 6 1116 1127 20352166 10.1160/TH09-11-0758
117. EM Hylek 2010 Therapeutic potential of oral factor Xa inhibitors N Engl J Med 363 26 2559 2561 21175319 1:CAS:528:DC%2BC3cXhs1Wht7%2FE 10.1056/NEJMe1012149
118. SJ Connolly J Eikelboom C Joyner HC Diener R Hart S Golitsyn G Flaker A Avezum SH Hohnloser R Diaz M Talajic J Zhu P Pais A Budaj A Parkhomenko P Jansky P Commerford RS Tan KH Sim BS Lewis W Van Mieghem GY Lip JH Kim F Lanas-Zanetti A Gonzalez-Hermosillo AL Dans M Munawar M O'Donnell J Lawrence G Lewis R Afzal S Yusuf 2011 Apixaban in patients with atrial fibrillation N Engl J Med 364 9 806 817 21309657 1:CAS:528:DC%2BC3MXivV2kurc%3D 10.1056/NEJMoa1007432
119. Berwaerts J, Dijkhuizen RS, Robb OJ, Webster J (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558-2562
120. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group (2004) Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181(9):492-497
121. Baglin TP, Keeling DM, Watson HG; British Committee for Standards in Haematology (2006) Guidelines on oral anticoagulation (warfarin): third edition-2005 update. Br J Haematol 132(3):277-285
122. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W (2006) Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22(4):294-316
123. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M; American Heart Association; American Stroke Association Stroke Council; High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group (2007) Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 38(6):2001-2023
124. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):160S-198S